Orange Book product · Generic (ANDA)
SODIUM BICARBONATE
SODIUM BICARBONATE
At a glance
Mar 07, 2017
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 07, 2017
9 yr 5 mo ago
Today
Pharmaceutical detail
Active ingredient
SODIUM BICARBONATE
Strength
5MEQ/10ML (0.5MEQ/ML)
Dosage form
SOLUTION
Route
INTRAVENOUS
TE code
AP
Application
ANDA 202679
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of SODIUM BICARBONATE
- 1986SODIUM BICARBONATE IN PLASTIC CONTAINERBrand (NDA)
NDA 019443 · ABBOTT
- 2026SODIUM BICARBONATEGeneric (ANDA)
ANDA 220788 · ASPIRO
- 2026SODIUM BICARBONATEGeneric (ANDA)
ANDA 217523 · AMNEAL
- 2025SODIUM BICARBONATEGeneric (ANDA)
ANDA 206688 · FRESENIUS KABI USA
- 2025SODIUM BICARBONATEGeneric (ANDA)
ANDA 219701 · ANTHEA PHARMA
- 2024SODIUM BICARBONATEGeneric (ANDA)
ANDA 216042 · LONG GROVE PHARMS
- 2023SODIUM BICARBONATEGeneric (ANDA)
ANDA 217594 · STERISCIENCE
- 2023SODIUM BICARBONATEGeneric (ANDA)
ANDA 216364 · OMNIVIUM PHARMS
- 2019SODIUM BICARBONATEGeneric (ANDA)
ANDA 211091 · EXELA PHARMA
- 2017SODIUM BICARBONATEGeneric (ANDA)
ANDA 202432 · HOSPIRA
- 2017SODIUM BICARBONATEGeneric (ANDA)
ANDA 203449 · INTL MEDICATION SYS
- 2017SODIUM BICARBONATEGeneric (ANDA)
ANDA 202495 · HOSPIRA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
